Do Higher Levels of Resilience Buffer the Deleterious Impact of Chronic Illness on Disability in Later Life?

TitleDo Higher Levels of Resilience Buffer the Deleterious Impact of Chronic Illness on Disability in Later Life?
Publication TypeJournal Article
Year of Publication2016
AuthorsManning, LK, Carr, DC, Kail, BLennox
Date Published2016 06
ISSN Number1758-5341
KeywordsActivities of Daily Living, Aged, Aged, 80 and over, Aging, Chronic disease, Disability Evaluation, Disabled Persons, Female, Humans, Longitudinal Studies, Male, Middle Aged, Resilience, Psychological, Retirement, Surveys and Questionnaires

PURPOSE OF THE STUDY: In examining the ability of resilience, or the ability to navigate adversity in a manner that protects well-being, to buffer the impact of chronic disease onset on disability in later life, the authors tested 2 hypotheses: (a) People with greater levels of resilience will have lower levels of disability and (b) resilience will moderate the association between the onset of a new chronic condition and subsequent disability.

DESIGN AND METHODS: This study used a sample of 10,753 Americans between the ages of 51 and 98, derived from 3 waves of the Health and Retirement Study (2006-2010). Ordinary least squares regression was used to estimate the impact of resilience on changes in disability (measured as difficulty with activities of daily living [ADLs] and instrumental activities of daily living [IADLs]) over a 2-year period using a simplified resilience score.

RESULTS: Resilience protects against increases in ADL and IADL limitations that are often associated with aging. Resilience mitigates a considerable amount of the deleterious consequences related to the onset of chronic illness and subsequent disability.

IMPLICATIONS: Our results support our hypotheses and are consistent with claims that high levels of resilience can protect against the negative impact of disability in later life.

User Guide Notes

Alternate JournalGerontologist
Citation Key8530
PubMed ID25063353
PubMed Central IDPMC4873762
Grant ListT32 AG000029 / AG / NIA NIH HHS / United States